LOGC Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 jun 2024 @ 20:46):
Our systems believe the stock currently is overvalued by -0.04% compare to its pairs and should correct downwards.

LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms...

Stats
Dagens volum	280 782
Gjennomsnittsvolum	669 787
Markedsverdi	142.91M
EPS	$-2.43 ( Q1 \| 2024-03-31 )
Neste inntjeningsdato	( $-0.0600 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-5.23 (Sector) 42.63 (Industry) 24.32
ATR14	$0.00500 (0.09%)

AADI -6.47%

ABCL 2.38%

ABCM 0.04%

ABEO -3.09%

ABIO -1.68%

ABOS 4.19%

ABSI 5.10%

ABUS -0.66%

ABVX -1.88%

ACAD -0.10%

ACER -17.95%

ACET -8.50%

ACGN 1.29%

ACHL -1.63%

ACHV 3.23%

ACIU -1.50%

ACLX 0.37%

ACRV -5.56%

ACST -4.89%

ACXP 3.93%

ADAG 6.07%

ADAP -3.29%

ADGI 0.87%

ADIL 0.88%

ADMA -1.86%

ADPT 0.74%

ADTX -2.78%

ADVM 1.01%

ADXN -1.60%

AEON -2.80%

AEZS -2.49%

AFMD -1.92%

AGEN -3.30%

AGIO -2.01%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 5.04%

AKRO -2.94%

AKTX -2.38%

AKUS 0.00%

ALBO 0.00%

ALDX -1.95%

ALEC -0.80%

ALGS 1.32%

ALKS 1.57%

ALLK -11.44%

ALLO -4.17%

ALLR -3.80%

ALNA 3.16%

ALNY 2.91%

ALPN 0.02%

ALPX 0.00%

ALRN -2.24%

ALT -13.77%

ALVR -0.67%

ALXN 0.00%

ALXO -13.70%

ALZN 4.02%

AMRN -1.77%

AMTI -3.13%

ANAB 1.47%

ANEB 3.13%

ANGN 0.00%

ANIX -3.06%

ANL -0.14%

ANNX 2.17%

ANPC -3.15%

APGE 0.13%

APGN 8.48%

APGNW 30.65%

APLM -5.82%

APLS 0.82%

APLT -0.90%

APM 1.26%

APOP 0.38%

APRE 0.84%

APTO 4.82%

APTX 3.17%

APVO 0.93%

ARAV -13.39%

ARCT -5.44%

ARDS -12.13%

ARDX 1.16%

ARGX -0.50%

ARNA 0.00%

ARPO -0.90%

ARQT -2.81%

ARTL -2.50%

ARTLW 0.00%

ARVN 6.69%

ARWR -1.67%

ASLN -3.24%

ASMB -4.22%

ASND -2.28%

ATAI -3.35%

ATHA 7.31%

ATHE 0.56%

ATHX -33.50%

ATNF 0.99%

ATOS 5.34%

ATRA -3.48%

ATXI 2.70%

ATXS -0.55%

AUPH -0.90%

AURA 4.55%

AUTL -3.02%

AVBP -3.33%

AVEO 0.00%

AVIR -2.33%

AVRO -1.41%

AVTE 0.00%

AVTX -3.74%

AVXL -5.05%

AXLA 0.00%

AXSM -1.21%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 2.42%

BCAB -1.96%

BCDA -3.15%

BCDAW -41.77%

BCEL 0.00%

BCLI 4.21%

BCRX 1.81%

BCTX 8.16%

BCTXW 13.02%

BCYC 0.90%

BDRX -3.13%

BDTX 0.21%

BEAM 2.60%

BFRA -2.91%

BGNE -2.21%

BIOR -5.27%

BIVI 3.03%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -3.39%

BLTE -1.03%

BLU 0.03%

BLUE -2.10%

BMEA -12.94%

BMRN 0.44%

BNOX 6.15%

BNTC -1.69%

BNTX -1.64%

BOLD -8.35%

BOLT -0.09%

BPMC -1.18%

BPTH -1.90%

BPTS -13.47%

BRNS -0.37%

BRTX -6.10%

BTAI 16.53%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 2.95%

CABA 0.97%

CADL 0.18%

CALA 0.00%

CALC -3.74%

CALT -1.59%

CAPR -1.08%

CARA -3.26%

CARM 6.96%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 0.56%

CCCC -2.33%

CCXI 0.00%

CDAK 0.00%

CDIO -5.08%

CDIOW 24.00%

CDMO -1.69%

CDMOP 0.04%

CDT -0.82%

CDTTW -39.60%

CDTX -4.77%

CDXC 7.17%

CDXS 9.31%

CELC -3.03%

CELU -1.83%

CELUW 11.80%

CERC -1.68%

CERE -1.74%

CERO -9.53%

CEROW -10.18%

CFRX -27.95%

CGEM 0.00%

CGEN -3.31%

CGON -1.72%

CGTX -4.35%

CHMA -6.00%

CHRS 4.13%

CINC 0.00%

CING -2.56%

CINGW 34.95%

CKPT -1.79%

CLBS -16.75%

CLDX -0.91%

CLGN 0.70%

CLLS -3.63%

CLNN 1.36%

CLNNW 0.00%

CLRB 6.67%

CLSD -2.40%

CLSN -0.68%

CLVS 0.00%

CMMB -3.89%

CMND 5.60%

CMPI 0.00%

CMPX -0.94%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.42%

CNCE 0.00%

CNSP -35.82%

CNST 0.00%

CNTA -0.11%

CNTB -0.75%

CNTX -4.79%

COCP -2.00%

COEPW 32.45%

COGT -2.05%

CORT 2.53%

COYA -0.64%

CPRX -1.95%

CRBP -0.49%

CRBU -6.82%

CRDF 1.11%

CRGX -0.03%

CRIS -3.19%

CRNX -6.00%

CRSP -0.23%

CRTX 2.63%

CRVO -2.60%

CRVS 0.56%

CSBR 0.11%

CTCX -1.59%

CTIC 0.06%

CTMX -3.31%

CTNM 1.98%

CTXR 0.21%

CUE -1.73%

CVAC -7.92%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 8.49%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -2.59%

CYTO 0.91%

DARE 3.54%

DAWN -0.90%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 28.76%

DNLI -1.66%

DNTH -4.64%

DOMH 1.59%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 1.43%

DSGN -2.42%

DTIL -0.24%

DYAI 9.68%

EARS -1.77%

EDIT -2.72%

EDSA 4.09%

EFTR 4.47%

EFTRW -53.85%

EIGR -9.21%

ELAB -3.01%

ELDN 8.82%

ELEV -1.66%

ELOX 10.77%

ELTX -5.15%

ELVN -1.91%

ELYM 4.60%

ENGN 0.87%

ENGNW 0.00%

ENLV 0.00%

ENOB 1.79%

ENSC 6.53%

ENTA 0.08%

ENTO -4.97%

ENTX -0.53%

ENVB 8.03%

EPIX -0.73%

EPRX -1.92%

EPZM 0.00%

EQ 0.18%

EQRX -2.09%

EQRXW 0.00%

ERAS -0.48%

ERNA -2.83%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -3.82%

ETON 3.35%

ETTX 0.00%

EVAX -0.71%

EVGN 4.76%

EVLO 0.00%

EWTX -1.73%

EXAI -0.29%

EXEL 0.38%

EYEG -0.69%

EYEN 0.67%

EYPT 1.76%

FATE -11.42%

FBIO 0.86%

FBIOP 0.87%

FBLG -7.40%

FBRX -0.02%

FDMT -4.91%

FENC -2.73%

FGEN -9.83%

FHTX 8.02%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.47%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 1.02%

FULC 1.92%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -0.43%

GANX -2.29%

GBIO -2.30%

GBT 0.01%

GDTC 0.50%

GERN -3.10%

GHRS -3.72%

GLMD -4.09%

GLPG -1.56%

GLSI 5.20%

GLTO -3.31%

GLUE -3.43%

GLYC -11.70%

GMAB -0.27%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.60%

GNLX -4.64%

GNPX -2.86%

GNTA 3.94%

GOSS -11.01%

GOVX -1.59%

GOVXW 10.89%

GPCR -6.38%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.38%

GRTX -1.66%

GTHX 0.45%

GUTS 3.00%

GXGXW 41.67%

GYRE -4.54%

HALO -1.75%

HARP 0.09%

HCWB -6.13%

HEPA -3.62%

HGEN -84.62%

HILS 5.66%

HLVX -1.34%

HOOK 0.89%

HOTH -1.11%

HOWL 2.14%

HRMY 4.72%

HRTX 9.02%

HSTO 0.00%

HUMA 1.22%

HUMAW -6.26%

IBRX -5.30%

ICCC -4.42%

ICPT 0.21%

ICU 18.71%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -3.07%

IFRX -2.77%

IGMS -1.32%

IKNA -0.30%

IKT -9.86%

IMAB 0.00%

IMCR -3.22%

IMGN 0.02%

IMGO 0.00%

IMMP 4.37%

IMMX -5.60%

IMNM 4.25%

IMNN 0.91%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.21%

IMTX -1.25%

IMTXW 6.00%

IMUX 1.85%

IMV 0.00%

IMVT -3.30%

INAB -1.66%

INBX -2.05%

INCY -2.25%

INDP 8.49%

INFI -52.38%

INKT 2.10%

INM -0.23%

INMB 4.19%

INO 3.25%

INSM -1.02%

INTS -1.96%

INVA 0.09%

INZY 2.06%

IOBT -10.94%

IONS 1.01%

IOVA -2.43%

IPA 3.00%

IPHA 3.05%

IPSC -2.34%

IRON -2.51%

ISEE 0.38%

ITOS 0.82%

ITRM 2.33%

IVA 6.96%

IVVD -0.41%

JAGX 1.24%

JANX -4.36%

JAZZ -0.92%

JNCE 0.00%

JSPR -1.60%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -2.45%

KALV -3.90%

KDNY 0.22%

KMPH -0.34%

KNSA -2.06%

KNTE -0.38%

KOD -7.51%

KPRX -5.52%

KPTI -7.80%

KRBP -10.00%

KRON 0.62%

KROS -0.55%

KRRO -0.36%

KRTX 0.03%

KRYS 0.38%

KTRA 11.05%

KTTA -0.65%

KTTAW 0.92%

KURA 0.24%

KYMR -2.87%

KYTX -3.23%

KZIA 4.41%

KZR -0.12%

LABP 0.57%

LBPH -0.30%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.01%

LENZ -3.27%

LEXX -1.16%

LEXXW -14.63%

LGND -1.29%

LGNDV 0.00%

LGVN -9.12%

LIAN -8.28%

LIFE 2.70%

LIPO -5.10%

LIXT -9.76%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 1.48%

LPCN -3.68%

LPTX -2.47%

LQDA 0.49%

LRMR 0.64%

LSTA -1.68%

LTRN 5.02%

LUMO 1.79%

LVTX -2.58%

LXEO -8.44%

LXRX -2.06%

LYEL -35.38%

LYRA 1.94%

MACK 0.10%

MBIO -11.34%

MBRX -1.43%

MCRB 3.07%

MDGL -2.08%

MDNA -13.16%

MDWD 3.56%

MDXG -2.21%

MEIP 0.00%

MESO -1.49%

MGNX -5.13%

MGTA -7.74%

MGTX -0.83%

MGX -2.34%

MIRM 0.03%

MIRO 0.59%

MIST 2.66%

MITO 0.00%

MLEC -7.68%

MLECW 2.31%

MLND -5.36%

MLTX 0.20%

MLYS -5.87%

MNKD -0.57%

MNMD 4.15%

MNOV 2.11%

MNPR -8.56%

MOLN 2.20%

MOR 0.45%

MORF -3.27%

MREO -2.57%

MRKR -0.43%

MRNA -8.72%

MRNS -5.51%

MRSN -2.86%

MRTX -0.17%

MRUS -0.75%

MRVI -0.87%

MTCR -1.29%

MTEM 6.93%

MTP -18.50%

MURA -4.17%

MYMD 1.08%

NAMS -0.65%

NAMSW -0.21%

NAUT 1.11%

NBRV 0.71%

NBSE -1.56%

NBTX 12.09%

NCNA 0.00%

NERV -1.58%

NEXI -0.74%

NGM -1.28%

NGNE 3.70%

NKGN 10.09%

NKGNW 8.00%

NKTR 3.76%

NKTX -4.40%

NLSP 3.53%

NLSPW 26.67%

NMRA -0.80%

NMTR -42.97%

NOVN -24.84%

NRBO 18.54%

NRIX -0.55%

NRSN -4.82%

NRSNW 0.00%

NRXP -7.84%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.63%

NTEC -12.45%

NTHI 0.00%

NTLA -5.17%

NTRBW -31.07%

NUVL -1.23%

NVAX -7.18%

NVCT -7.75%

NVIV -34.28%

NXTC -3.53%

NYMX -0.05%

OABI 2.77%

OABIW -10.06%

OBIO -1.17%

OBSV 0.00%

OCEA -2.11%

OCGN 10.15%

OCS -1.00%

OCUL 0.91%

OCUP 0.65%

ODT -4.27%

OKYO 2.15%

OLMA -5.03%

OMER -2.83%

OMGA 0.83%

ONCO 5.89%

ONCR -3.08%

ONCS 31.87%

ONCT -2.35%

ONCY 3.47%

ONTX -0.47%

ONVO 0.29%

OPNT 0.00%

OPT 2.06%

ORGS 1.19%

ORIC -1.34%

ORMP 18.30%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.18%

OVID 0.01%

OYST 0.00%

PALI -0.22%

PASG 2.63%

PBLA -7.50%

PBM -4.70%

PBYI 2.87%

PCSA -1.93%

PCVX 0.06%

PDSB -6.17%

PEPG 1.37%

PGEN -5.68%

PHAR 2.19%

PHAS 0.00%

PHAT -0.10%

PHIO -3.58%

PHIOW 36.47%

PHVS -5.83%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -2.01%

PLUR 7.39%

PMN -5.55%

PMVP -2.38%

PNT 0.16%

PPBT -6.43%

PRAX 6.82%

PRDS 0.93%

PRLD -2.64%

PROG -3.47%

PROK -0.45%

PRQR 1.21%

PRTA -2.50%

PRTC 0.62%

PRTG 1.00%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -14.04%

PSTX -2.71%

PTCT -0.63%

PTE -0.82%

PTGX -0.87%

PTIXW -48.41%

PULM 1.53%

PXMD 4.76%

PYPD 1.71%

PYXS 4.41%

QLGN -7.18%

QNCX 5.70%

QNRX -0.49%

QSI -35.89%

QSIAW -3.13%

QTTB -0.14%

QURE -0.34%

RAIN -1.63%

RANI 4.81%

RAPT -1.61%

RARE 1.88%

RCKT -8.97%

REGN -0.44%

RENB -2.52%

REPL -1.93%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 5.00%

RGLS -5.61%

RGNX -6.49%

RIGL -6.36%

RLAY -4.75%

RLMD 0.00%

RLYB -4.70%

RNA 1.17%

RNAC -4.45%

RNAZ 0.00%

RNXT 0.88%

ROIV -1.62%

ROIVW 4.56%

RPHM -0.93%

RPRX -0.67%

RPTX -0.59%

RUBY 2.70%

RVLP -32.05%

RVMD -0.46%

RVMDW -29.90%

RVNC -0.64%

RVPH -1.19%

RVPHW -5.28%

RXDX 0.09%

RXRX -5.76%

RYTM -5.68%

RYZB 0.02%

RZLT 2.58%

SABS -1.37%

SABSW -11.81%

SAGE 0.46%

SANA -2.59%

SAVA -1.45%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 2.65%

SCPH 10.10%

SCPS 0.00%

SEEL -3.22%

SEER 0.29%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.41%

SGMT -5.07%

SGTX -2.56%

SIOX 22.63%

SLDB -2.72%

SLGL 5.23%

SLN -7.25%

SLNO 0.23%

SLRX 1.23%

SLS -2.58%

SMMT -3.50%

SNDX 3.07%

SNGX -0.38%

SNPX -2.56%

SONN -0.01%

SPPI -0.49%

SPRB -1.59%

SPRC -4.25%

SPRO 0.75%

SRNE 0.00%

SRPT -1.20%

SRRA 0.00%

SRRK -1.55%

SRZN -2.45%

STAB 0.00%

STOK -6.81%

STRO -1.84%

STSA 0.00%

STTK 5.77%

SURF -0.93%

SVRA -1.35%

SWTX 0.05%

SYBX 1.29%

SYRS -1.98%

TALS -0.73%

TARA -7.38%

TARS -1.92%

TBPH 0.71%

TCBP 5.56%

TCDA 0.00%

TCON 0.00%

TCRR 0.00%

TCRT -1.75%

TCRX 4.52%

TECH -0.75%

TENX -0.32%

TERN -9.12%

TFFP -7.61%

TGTX -7.08%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -7.23%

TNGX -3.24%

TNXP -6.00%

TNYA -4.73%

TPST 5.74%

TRDA -4.67%

TRVI 2.68%

TRVN 0.82%

TSHA -20.08%

TSVT -4.26%

TTNP -6.05%

TVTX 3.02%

TYRA -6.95%

UBX -2.55%

UNCY -3.82%

URGN 2.33%

UTHR -0.02%

VACC 11.36%

VALN -6.70%

VAXX 118.69%

VBIV 0.93%

VBLT -8.77%

VCEL 0.86%

VCNX 9.03%

VCYT -0.79%

VERA -5.79%

VERU 1.30%

VERV -2.20%

VIGL -1.08%

VINC 2.99%

VIR -0.60%

VIRI -4.53%

VIRX 3.98%

VKTX -1.67%

VLON -13.04%

VNDA -3.86%

VOR -6.05%

VRCA 0.07%

VRDN -3.30%

VRNA -1.66%

VRPX 1.02%

VRTX 0.04%

VSTM 3.23%

VTGN -1.66%

VTVT 0.39%

VTYX -2.72%

VXRT -2.26%

VYGR -0.77%

VYNE -5.17%

VYNT 7.78%

WINT -0.60%

WVE -8.18%

XBIO 1.03%

XBIT 7.29%

XCUR 3.77%

XENE -1.97%

XERS 5.24%

XFOR 5.73%

XLO 4.42%

XLRN 0.00%

XNCR 0.26%

XOMA -10.03%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.63%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.64%

ZNTL -1.46%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2022-11-16	Kay Mark A	Sell	12 500	Stock Option (right to buy)
2022-11-16	Enyedy Mark J	Sell	12 500	Stock Option (right to buy)
2022-11-16	Nacht Mariana	Sell	100 000	Stock Option (right to buy)
2022-11-16	Wyzga Michael S	Sell	12 500	Stock Option (right to buy)
2022-11-16	Chereau Frederic	Sell	328 000	Stock Option (right to buy)

INSIDER POWER
-97.72
Last 94 transactions
Buy: 5 628 346 \| Sell: 1 216 285

Korrelasjon (AI algo v.1.1b): Overvalued: -0.04% $5.84 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Volum Korrelasjon

Lang: 0.09 (neutral)

Kort: 0.66 (moderate)

Signal:(42.852) Neutral

LogicBio Therapeutics, Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

LogicBio Therapeutics, Korrelasjon - Valuta/Råvare

-0.32
( neutral )

0.27
( neutral )

0.00
( neutral )

-0.70
( moderate negative )

LogicBio Therapeutics, Økonomi

Annual	2023
Omsetning:	$287.00M
Bruttogevinst:	$59.00M (20.56 %)
EPS:	$-13.36

FY	2023
Omsetning:	$287.00M
Bruttogevinst:	$59.00M (20.56 %)
EPS:	$-13.36

FY	2021
Omsetning:	$5.41M
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-1.240

FY	2020
Omsetning:	$3.45M
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-1.290

Financial Reports:

No articles found.

LogicBio Therapeutics, Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

LogicBio Therapeutics,

LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company\'s GeneRide technology is a new approach to precise gene insertion harnessing a cell\'s natural deoxyribonucleic acid; and gene delivery platform, sAAVy is an adeno-associated virus, which is designed to optimize gene delivery for treatments in a range of indications and tissues. Its lead product candidate is LB-001 that is in Phase I/II clinical trials for the treatment of methylmalonic acidemia. The company has a collaboration with Children\'s Medical Research Institute to develop next-generation capsids for gene therapy and gene editing applications in the liver, as well as additional tissues; and a collaboration agreement with Takeda Pharmaceutical Company Limited to develop LB-301, an investigational therapy for the treatment of Crigler-Najjar syndrome. The company also has a research collaboration, license, and option agreement with CANbridge Care Pharma Hong Kong Limited; and collaboration agreement with Daiichi Sankyo Company. The company was incorporated in 2014 and is headquartered in Lexington, Massachusetts. As of November 15, 2022, LogicBio Therapeutics, Inc. operates as a subsidiary of Alexion Pharmaceuticals, Inc..